{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:12:48Z","timestamp":1778191968462,"version":"3.51.4"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02762-x","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:05:13Z","timestamp":1772496313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TARDBP as a regulator of HIV-1 assembly and infection: a review of targeting the viral capsid precursor Pr55Gag and limiting viral core entry"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5671-6196","authenticated-orcid":false,"given":"Romina","family":"Cabrera-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pons-Grifols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2966-0160","authenticated-orcid":false,"given":"Mar\u00eda","family":"Pernas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3412-2877","authenticated-orcid":false,"given":"Concepci\u00f3n","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7321-5430","authenticated-orcid":false,"given":"Rodrigo","family":"Trujillo-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iria","family":"Lorenzo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iriome","family":"Reyes-Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3809-042X","authenticated-orcid":false,"given":"Benjamin","family":"Trinit\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-0217","authenticated-orcid":false,"given":"Juli\u00e0","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2585-8703","authenticated-orcid":false,"given":"Agustin","family":"Valenzuela-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2762_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cell.2007.08.018","volume":"131","author":"BK Ganser-Pornillos","year":"2007","unstructured":"Ganser-Pornillos BK, Cheng A, Yeager M. Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell. 2007;131:70\u20139.","journal-title":"Cell"},{"key":"2762_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.283.5398.80","volume":"283","author":"BK Ganser","year":"1999","unstructured":"Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. Assembly and analysis of conical models for the HIV-1 core. Science. 1999;283:80\u20133.","journal-title":"Science"},{"key":"2762_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nature12162","volume":"497","author":"G Zhao","year":"2013","unstructured":"Zhao G, Perilla JR, Yufenyuy EL, Meng X, Chen B, Ning J, Ahn J, Gronenborn AM, Schulten K, Aiken C, Zhang P. Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics. Nature. 2013;497:643\u20136.","journal-title":"Nature"},{"key":"2762_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nsmb785","volume":"11","author":"JA Briggs","year":"2004","unstructured":"Briggs JA, Simon MN, Gross I, Krausslich HG, Fuller SD, Vogt VM, Johnson MC. The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol. 2004;11:672\u20135.","journal-title":"Nat Struct Mol Biol"},{"key":"2762_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/35030177","volume":"407","author":"S Li","year":"2000","unstructured":"Li S, Hill CP, Sundquist WI, Finch JT. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature. 2000;407:409\u201313.","journal-title":"Nature"},{"key":"2762_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nrmicro3503","volume":"13","author":"EM Campbell","year":"2015","unstructured":"Campbell EM, Hope TJ. HIV-1 capsid: the multifaceted key player in HIV-1 infection. Nat Rev Microbiol. 2015;13:471\u201383.","journal-title":"Nat Rev Microbiol"},{"key":"2762_CR7","unstructured":"Department of Health and Human Services (Washington D: Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. HHS Panel on Antiretroviral Guidelines for Adults and Adolescents\u2014A Working Group of the NIH Office of AIDS Research Advisory Council (OARAC). 2024. https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/guidelines-adult-adolescent-arv.pdf."},{"key":"2762_CR8","doi-asserted-by":"crossref","unstructured":"Sever B, Otsuka M, Fujita M, Ciftci H. A review of FDA-approved anti-HIV-1 drugs, anti-gag compounds, and potential strategies for HIV-1 eradication. Int J Mol Sci. 2024;25:3659.","DOI":"10.3390\/ijms25073659"},{"key":"2762_CR9","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa2115542","volume":"386","author":"S Segal-Maurer","year":"2022","unstructured":"Segal-Maurer S, DeJesus E, Stellbrink HJ, Castagna A, Richmond GJ, Sinclair GI, Siripassorn K, Ruane PJ, Berhe M, Wang H, et al. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection. N Engl J Med. 2022;386:1793\u2013803.","journal-title":"N Engl J Med"},{"key":"2762_CR10","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"LG Bekker","year":"2024","unstructured":"Bekker LG, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W, Gill K, Harkoo I, Jaggernath M, Kigozi G, et al. Twice-Yearly Lenacapavir or Daily F\/TAF for HIV Prevention in Cisgender Women. N Engl J Med. 2024;391:1179\u201392.","journal-title":"N Engl J Med"},{"key":"2762_CR11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41586-020-2443-1","volume":"584","author":"JO Link","year":"2020","unstructured":"Link JO, Rhee MS, Tse WC, Zheng J, Somoza JR, Rowe W, Begley R, Chiu A, Mulato A, Hansen D, et al. Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature. 2020;584:614\u20138.","journal-title":"Nature"},{"key":"2762_CR12","doi-asserted-by":"crossref","unstructured":"Bekerman E, Yant SR, VanderVeen L, Hansen D, Lu B, Rowe W, et al. Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model. J Clin Invest. 2023;133:e167818.","DOI":"10.1172\/JCI167818"},{"key":"2762_CR13","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/jac\/dkaa060","volume":"75","author":"AG Marcelin","year":"2020","unstructured":"Marcelin AG, Charpentier C, Jary A, Perrier M, Margot N, Callebaut C, Calvez V, Descamps D. Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients. J Antimicrob Chemother. 2020;75:1588\u201390.","journal-title":"J Antimicrob Chemother"},{"key":"2762_CR14","doi-asserted-by":"crossref","unstructured":"Dzinamarira T, Almehmadi M, Alsaiari AA, Allahyani M, Aljuaid A, Alsharif A, et al. Highlights on the development, related patents, and prospects of Lenacapavir: the first-in-class HIV-1 Capsid inhibitor for the treatment of multi-drug-resistant HIV-1 Infection. Med (Kaunas). 2023;59:1041.","DOI":"10.3390\/medicina59061041"},{"key":"2762_CR15","doi-asserted-by":"publisher","first-page":"107009","DOI":"10.1016\/j.ijantimicag.2023.107009","volume":"63","author":"AM Hitchcock","year":"2024","unstructured":"Hitchcock AM, Kufel WD, Dwyer KAM, Sidman EF. Lenacapavir: A novel injectable HIV-1 capsid inhibitor. Int J Antimicrob Agents. 2024;63:107009.","journal-title":"Int J Antimicrob Agents"},{"key":"2762_CR16","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1021\/acs.molpharmaceut.3c00626","volume":"20","author":"R Subramanian","year":"2023","unstructured":"Subramanian R, Tang J, Zheng J, Lu B, Wang K, Yant SR, Stepan GJ, Mulato A, Yu H, Schroeder S, et al. Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent. Mol Pharm. 2023;20:6213\u201325.","journal-title":"Mol Pharm"},{"key":"2762_CR17","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1126\/science.abb4808","volume":"370","author":"SM Bester","year":"2020","unstructured":"Bester SM, Wei G, Zhao H, Adu-Ampratwum D, Iqbal N, Courouble VV, Francis AC, Annamalai AS, Singh PK, Shkriabai N, et al. Structural and mechanistic bases for a potent HIV-1 capsid inhibitor. Science. 2020;370:360\u20134.","journal-title":"Science"},{"key":"2762_CR18","doi-asserted-by":"crossref","unstructured":"Li YL, Chandrasekaran V, Carter SD, Woodward CL, Christensen DE, Dryden KA, et al. Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids. Elife. 2016;5:e16269.","DOI":"10.7554\/eLife.16269"},{"key":"2762_CR19","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nature02343","volume":"427","author":"M Stremlau","year":"2004","unstructured":"Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 2004;427:848\u201353.","journal-title":"Nature"},{"key":"2762_CR20","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1128\/JVI.02318-06","volume":"81","author":"MJ Perron","year":"2007","unstructured":"Perron MJ, Stremlau M, Lee M, Javanbakht H, Song B, Sodroski J. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J Virol. 2007;81:2138\u201348.","journal-title":"J Virol"},{"key":"2762_CR21","doi-asserted-by":"crossref","unstructured":"Wagner JM, Roganowicz MD, Skorupka K, Alam SL, Christensen D, Doss G, et al. Mechanism of B-box 2 domain-mediated higher-order assembly of the retroviral restriction factor TRIM5alpha. Elife. 2016;5:e16309.","DOI":"10.7554\/eLife.16309"},{"key":"2762_CR22","doi-asserted-by":"crossref","unstructured":"Wagner JM, Christensen DE, Bhattacharya A, Dawidziak DM, Roganowicz MD, Wan Y, et al. General model for retroviral capsid pattern recognition by TRIM5 proteins. J Virol. 2018;92:e01563\u201317.","DOI":"10.1128\/JVI.01563-17"},{"key":"2762_CR23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.virol.2006.03.023","volume":"351","author":"F Diaz-Griffero","year":"2006","unstructured":"Diaz-Griffero F, Vandegraaff N, Li Y, McGee-Estrada K, Stremlau M, Welikala S, Si Z, Engelman A, Sodroski J. Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology. 2006;351:404\u201319.","journal-title":"Virology"},{"key":"2762_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virol.2007.04.034","volume":"367","author":"H Javanbakht","year":"2007","unstructured":"Javanbakht H, Diaz-Griffero F, Yuan W, Yeung DF, Li X, Song B, Sodroski J. The ability of multimerized cyclophilin A to restrict retrovirus infection. Virology. 2007;367:19\u201329.","journal-title":"Virology"},{"key":"2762_CR25","doi-asserted-by":"publisher","first-page":"e1003214","DOI":"10.1371\/journal.ppat.1003214","volume":"9","author":"SB Kutluay","year":"2013","unstructured":"Kutluay SB, Perez-Caballero D, Bieniasz PD. Fates of retroviral core components during unrestricted and TRIM5-restricted infection. PLoS Pathog. 2013;9:e1003214.","journal-title":"PLoS Pathog"},{"key":"2762_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1742-4690-8-93","volume":"8","author":"Z Lukic","year":"2011","unstructured":"Lukic Z, Hausmann S, Sebastian S, Rucci J, Sastri J, Robia SL, Luban J, Campbell EM. TRIM5alpha associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology. 2011;8:93.","journal-title":"Retrovirology"},{"key":"2762_CR27","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1600-0854.2012.01381.x","volume":"13","author":"CM Danielson","year":"2012","unstructured":"Danielson CM, Cianci GC, Hope TJ. Recruitment and dynamics of proteasome association with rhTRIM5alpha cytoplasmic complexes during HIV-1 infection. Traffic. 2012;13:1206\u201317.","journal-title":"Traffic"},{"key":"2762_CR28","doi-asserted-by":"crossref","unstructured":"Danielson CM, Hope TJ. Using antiubiquitin antibodies to probe the ubiquitination state within rhTRIM5\u03b1 cytoplasmic bodies. AIDS Res Hum Retroviruses. 2013;29:1373\u201385.","DOI":"10.1089\/aid.2013.0029"},{"key":"2762_CR29","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1128\/JVI.05811-11","volume":"86","author":"A Roa","year":"2012","unstructured":"Roa A, Hayashi F, Yang Y, Lienlaf M, Zhou J, Shi J, Watanabe S, Kigawa T, Yokoyama S, Aiken C, Diaz-Griffero F. RING domain mutations uncouple TRIM5alpha restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. J Virol. 2012;86:1717\u201327.","journal-title":"J Virol"},{"key":"2762_CR30","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.15252\/embj.201490361","volume":"34","author":"AJ Fletcher","year":"2015","unstructured":"Fletcher AJ, Christensen DE, Nelson C, Tan CP, Schaller T, Lehner PJ, Sundquist WI, Towers GJ. TRIM5alpha requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription. EMBO J. 2015;34:2078\u201395.","journal-title":"EMBO J"},{"key":"2762_CR31","doi-asserted-by":"crossref","unstructured":"Campbell EM, Weingart J, Sette P, Opp S, Sastri J, O\u2019Connor SK, et al. TRIM5\u03b1-mediated ubiquitin chain conjugation is required for inhibition of HIV-1 reverse transcription and capsid destabilization. J Virol. 2015;90:1849\u201357.","DOI":"10.1128\/JVI.01948-15"},{"key":"2762_CR32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2217\/fvl.14.25","volume":"9","author":"A Kirmaier","year":"2014","unstructured":"Kirmaier A, Krupp A, Johnson WE. Understanding restriction factors and intrinsic immunity: insights and lessons from the primate lentiviruses. Future Virol. 2014;9:483\u201397.","journal-title":"Future Virol"},{"key":"2762_CR33","first-page":"114","volume":"9","author":"RM Newman","year":"2007","unstructured":"Newman RM, Johnson WE. A brief history of TRIM5alpha. AIDS Rev. 2007;9:114\u201325.","journal-title":"AIDS Rev"},{"key":"2762_CR34","doi-asserted-by":"crossref","unstructured":"Liu FL, Qiu YQ, Li H, Kuang YQ, Tang X, Cao G, et al. An HIV-1 resistance polymorphism in TRIM5\u03b1 gene among Chinese intravenous drug users. J Acquir Immune Defic Syndr. 2011;56:306\u201311.","DOI":"10.1097\/QAI.0b013e318205a59b"},{"key":"2762_CR35","doi-asserted-by":"crossref","unstructured":"Price H, Lacap P, Tuff J, Wachihi C, Kimani J, Ball TB, et al. A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort. AIDS. 2010;24:1813\u201321.","DOI":"10.1097\/QAD.0b013e32833b5256"},{"key":"2762_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.virol.2006.06.031","volume":"354","author":"H Javanbakht","year":"2006","unstructured":"Javanbakht H, An P, Gold B, Petersen DC, O\u2019Huigin C, Nelson GW, O\u2019Brien SJ, Kirk GD, Detels R, Buchbinder S, et al. Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology. 2006;354:15\u201327.","journal-title":"Virology"},{"key":"2762_CR37","doi-asserted-by":"publisher","first-page":"15567","DOI":"10.1128\/JVI.79.24.15567-15572.2005","volume":"79","author":"D Perez-Caballero","year":"2005","unstructured":"Perez-Caballero D, Hatziioannou T, Zhang F, Cowan S, Bieniasz PD. Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J Virol. 2005;79:15567\u201372.","journal-title":"J Virol"},{"key":"2762_CR38","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1073\/pnas.0510483103","volume":"103","author":"X Wu","year":"2006","unstructured":"Wu X, Anderson JL, Campbell EM, Joseph AM, Hope TJ. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci U S A. 2006;103:7465\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2762_CR39","doi-asserted-by":"crossref","unstructured":"Anderson JL, Campbell Em Fau - Wu X, Wu X, Fau - Vandegraaff N, Vandegraaff N, Fau - Engelman A, Engelman A, Fau - Hope TJ, Hope TJ. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. 2006.","DOI":"10.1128\/JVI.01052-06"},{"key":"2762_CR40","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1128\/JVI.02412-09","volume":"84","author":"C O\u2019Connor","year":"2010","unstructured":"O\u2019Connor C, Pertel T, Gray S, Robia SL, Bakowska JC, Luban J, Campbell EM. p62\/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha. J Virol. 2010;84:5997\u20136006.","journal-title":"J Virol"},{"key":"2762_CR41","doi-asserted-by":"crossref","unstructured":"Mandell MA, Jain A, Arko-Mensah J, Chauhan S, Kimura T, Dinkins C, et al. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev Cell. 2014;30:394\u2013409.","DOI":"10.1016\/j.devcel.2014.06.013"},{"key":"2762_CR42","doi-asserted-by":"crossref","unstructured":"Keown JR, Black MM, Ferron A, Yap M, Barnett MJ, Pearce FG, et al. A helical LC3-interacting region mediates the interaction between the retroviral restriction factor Trim5\u03b1 and mammalian autophagy-related ATG8 proteins. J Biol Chem. 2018;293:18378\u201386.","DOI":"10.1074\/jbc.RA118.004202"},{"key":"2762_CR43","doi-asserted-by":"crossref","unstructured":"Tanida I, Ueno T, Fau - Kominami E, Kominami E. LC3 and autophagy. Methods Mol Biol. 2008;445:77\u201388.","DOI":"10.1007\/978-1-59745-157-4_4"},{"key":"2762_CR44","doi-asserted-by":"crossref","unstructured":"Imam S, Talley S, Nelson RS, Dharan A, O\u2019Connor C, Hope TJ, et al. TRIM5\u03b1 degradation via Autophagy is not required for retroviral restriction. J Virol. 2016;90:3400\u201310.","DOI":"10.1128\/JVI.03033-15"},{"key":"2762_CR45","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/v5020470","volume":"5","author":"J Melchjorsen","year":"2013","unstructured":"Melchjorsen J. Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines. Viruses. 2013;5:470\u2013527.","journal-title":"Viruses"},{"key":"2762_CR46","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/bies.201400019","volume":"36","author":"J Maelfait","year":"2014","unstructured":"Maelfait J, Seiradake E, Rehwinkel J. Keeping your armour intact: how HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS. BioEssays. 2014;36:649\u201357.","journal-title":"BioEssays"},{"key":"2762_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature12769","volume":"503","author":"J Rasaiyaah","year":"2013","unstructured":"Rasaiyaah J, Tan CP, Fletcher AJ, Price AJ, Blondeau C, Hilditch L, Jacques DA, Selwood DL, James LC, Noursadeghi M, Towers GJ. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature. 2013;503:402\u20135.","journal-title":"Nature"},{"key":"2762_CR48","first-page":"121","volume":"133","author":"L Marek","year":"2020","unstructured":"Marek L, Wiki J, Campbell M, Kingham S, Sabel C, Tomintz M, Hobbs M. Slipping under the radar: worsened health outcomes in semi-urban areas of New Zealand. N Z Med J. 2020;133:121\u20135.","journal-title":"N Z Med J"},{"key":"2762_CR49","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature12707","volume":"503","author":"SP Goff","year":"2013","unstructured":"Goff SP. HIV: Slipping under the radar. Nature. 2013;503:352\u20133.","journal-title":"Nature"},{"key":"2762_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.chom.2010.02.007","volume":"7","author":"K Lee","year":"2010","unstructured":"Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, et al. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe. 2010;7:221\u201333.","journal-title":"Cell Host Microbe"},{"key":"2762_CR51","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/0092-8674(93)90637-6","volume":"73","author":"J Luban","year":"1993","unstructured":"Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell. 1993;73:1067\u201378.","journal-title":"Cell"},{"key":"2762_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coviro.2013.11.003","volume":"4","author":"L Hilditch","year":"2014","unstructured":"Hilditch L, Towers GJ. A model for cofactor use during HIV-1 reverse transcription and nuclear entry. Curr Opin Virol. 2014;4:32\u20136.","journal-title":"Curr Opin Virol"},{"key":"2762_CR53","doi-asserted-by":"publisher","first-page":"e1002439","DOI":"10.1371\/journal.ppat.1002439","volume":"7","author":"T Schaller","year":"2011","unstructured":"Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, Roth SL, Hue S, Fletcher AJ, Lee K, KewalRamani VN, et al. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog. 2011;7:e1002439.","journal-title":"PLoS Pathog"},{"key":"2762_CR54","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1128\/JVI.05887-11","volume":"86","author":"Z Ambrose","year":"2012","unstructured":"Ambrose Z, Lee K, Ndjomou J, Xu H, Oztop I, Matous J, Takemura T, Unutmaz D, Engelman A, Hughes SH, KewalRamani VN. Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection. J Virol. 2012;86:4708\u201314.","journal-title":"J Virol"},{"key":"2762_CR55","doi-asserted-by":"crossref","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339:786\u201391.","DOI":"10.1126\/science.1232458"},{"key":"2762_CR56","doi-asserted-by":"publisher","first-page":"e103958","DOI":"10.15252\/embj.2019103958","volume":"39","author":"RP Sumner","year":"2020","unstructured":"Sumner RP, Harrison L, Touizer E, Peacock TP, Spencer M, Zuliani-Alvarez L, Towers GJ. Disrupting HIV-1 capsid formation causes cGAS sensing of viral DNA. EMBO J. 2020;39:e103958.","journal-title":"EMBO J"},{"key":"2762_CR57","doi-asserted-by":"crossref","unstructured":"Cabrera-Rodriguez R, Perez-Yanes S, Lorenzo-Sanchez I, Estevez-Herrera J, Garcia-Luis J, Trujillo-Gonzalez R, et al. TDP-43 controls HIV-1 viral production and virus infectiveness. Int J Mol Sci. 2023;24:7658.","DOI":"10.3390\/ijms24087658"},{"key":"2762_CR58","doi-asserted-by":"crossref","unstructured":"Cabrera-Rodriguez R, Perez-Yanes S, Montelongo R, Lorenzo-Salazar JM, Estevez-Herrera J, Garcia-Luis J, et al. Transactive response dna-Binding Protein (TARDBP\/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6. Int J Mol Sci. 2022;23:6180.","DOI":"10.3390\/ijms23116180"},{"key":"2762_CR59","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s40478-024-01914-9","volume":"12","author":"J Zeng","year":"2024","unstructured":"Zeng J, Luo C, Jiang Y, Hu T, Lin B, Xie Y, Lan J, Miao J. Decoding TDP-43: the molecular chameleon of neurodegenerative diseases. Acta Neuropathol Commun. 2024;12:205.","journal-title":"Acta Neuropathol Commun"},{"key":"2762_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","volume":"603","author":"AL Brown","year":"2022","unstructured":"Brown AL, Wilkins OG, Keuss MJ, Hill SE, Zanovello M, Lee WC, Bampton A, Lee FCY, Masino L, Qi YA, et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603:131\u20137.","journal-title":"Nature"},{"key":"2762_CR61","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4161\/rna.7.4.12205","volume":"7","author":"E Buratti","year":"2010","unstructured":"Buratti E, Baralle FE. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 2010;7:420\u20139.","journal-title":"RNA Biol"},{"key":"2762_CR62","doi-asserted-by":"publisher","first-page":"15635","DOI":"10.1074\/jbc.M111.333450","volume":"287","author":"C Colombrita","year":"2012","unstructured":"Colombrita C, Onesto E, Megiorni F, Pizzuti A, Baralle FE, Buratti E, Silani V, Ratti A. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J Biol Chem. 2012;287:15635\u201347.","journal-title":"J Biol Chem"},{"key":"2762_CR63","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nn.2778","volume":"14","author":"JR Tollervey","year":"2011","unstructured":"Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, Konig J, Hortobagyi T, Nishimura AL, Zupunski V, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci. 2011;14:452\u20138.","journal-title":"Nat Neurosci"},{"key":"2762_CR64","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nn.2779","volume":"14","author":"M Polymenidou","year":"2011","unstructured":"Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14:459\u201368.","journal-title":"Nat Neurosci"},{"key":"2762_CR65","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1073\/pnas.1112427109","volume":"109","author":"Y Kawahara","year":"2012","unstructured":"Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A. 2012;109:3347\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2762_CR66","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/nan.12148","volume":"40","author":"JR Highley","year":"2014","unstructured":"Highley JR, Kirby J, Jansweijer JA, Webb PS, Hewamadduma CA, Heath PR, Higginbottom A, Raman R, Ferraiuolo L, Cooper-Knock J, et al. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones. Neuropathol Appl Neurobiol. 2014;40:670\u201385.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2762_CR67","doi-asserted-by":"publisher","first-page":"755096","DOI":"10.3389\/fonc.2021.755096","volume":"11","author":"X Ma","year":"2021","unstructured":"Ma X, Ying Y, Xie H, Liu X, Wang X, Li J. The Regulatory Role of RNA Metabolism Regulator TDP-43 in Human Cancer. Front Oncol. 2021;11:755096.","journal-title":"Front Oncol"},{"key":"2762_CR68","doi-asserted-by":"crossref","unstructured":"Ma XA-O, Prudencio MA-O, Koike YA-O, Vatsavayai SC, Kim GA-O, Harbinski F, et al. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature. 2022;603:124\u201330.","DOI":"10.1038\/s41586-022-04424-7"},{"key":"2762_CR69","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1074\/jbc.M110.190884","volume":"286","author":"CF Sephton","year":"2011","unstructured":"Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y, Dewey CM, Roth FP, Herz J, Peng J, et al. Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem. 2011;286:1204\u201315.","journal-title":"J Biol Chem"},{"key":"2762_CR70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/emboj.2009.324","volume":"29","author":"FC Fiesel","year":"2010","unstructured":"Fiesel FC, Voigt A, Weber SS, Van den Haute C, Waldenmaier A, Gorner K, Walter M, Anderson ML, Kern JV, Rasse TM, et al. Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J. 2010;29:209\u201321.","journal-title":"EMBO J"},{"key":"2762_CR71","doi-asserted-by":"publisher","first-page":"13302","DOI":"10.1074\/jbc.M800342200","volume":"283","author":"MJ Winton","year":"2008","unstructured":"Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem. 2008;283:13302\u20139.","journal-title":"J Biol Chem"},{"key":"2762_CR72","doi-asserted-by":"publisher","first-page":"36337","DOI":"10.1074\/jbc.M104236200","volume":"276","author":"E Buratti","year":"2001","unstructured":"Buratti E, Baralle FE. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem. 2001;276:36337\u201343.","journal-title":"J Biol Chem"},{"key":"2762_CR73","doi-asserted-by":"publisher","unstructured":"Cabrera-Rodr\u00edguez R, Pons-Grifols A, Pernas M, Casado C, Trujillo-Gonz\u00e1lez R, Lorenzo-S\u00e1nchez I, et al. TARDBP as a gatekeeper of HIV-1 assembly and infection: targeting the viral capsid precursor Pr55Gag and limiting viral core entry. Preprints 2025:2025101788. https:\/\/doi.org\/10.20944\/preprints202510.1788.v1.","DOI":"10.20944\/preprints202510.1788.v1"},{"key":"2762_CR74","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/417455a","volume":"417","author":"C Hubbert","year":"2002","unstructured":"Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP. HDAC6 is a microtubule-associated deacetylase. Nature. 2002;417:455\u20138.","journal-title":"Nature"},{"key":"2762_CR75","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1242\/jcs.046813","volume":"122","author":"Y Zilberman","year":"2009","unstructured":"Zilberman Y, Ballestrem C, Carramusa L, Mazitschek R, Khochbin S, Bershadsky A. Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J Cell Sci. 2009;122:3531\u201341.","journal-title":"J Cell Sci"},{"key":"2762_CR76","doi-asserted-by":"crossref","unstructured":"Casado C, Marrero-Hernandez S, Marquez-Arce D, Pernas M, Marfil S, Borras-Granana F, Olivares I, et al. Viral characteristics associated with the clinical nonprogressor phenotype are inherited by viruses from a cluster of HIV-1 elite controllers. mBio. 2018;9:e02338\u201317.","DOI":"10.1128\/mBio.02338-17"},{"key":"2762_CR77","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Yanes S, Pernas M, Marfil S, Cabrera-Rodr\u00edguez R, Ortiz R, Urrea V, et al. The characteristics of the HIV-1 Env Glycoprotein are linked with viral pathogenesis. Front Microbiol. 2022;13:763039.","DOI":"10.3389\/fmicb.2022.763039"},{"key":"2762_CR78","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1091\/mbc.e05-04-0354","volume":"16","author":"A Valenzuela-Fernandez","year":"2005","unstructured":"Valenzuela-Fernandez A, Alvarez S, Gordon-Alonso M, Barrero M, Ursa A, Cabrero JR, Fernandez G, Naranjo-Suarez S, Yanez-Mo M, Serrador JM, et al. Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. Mol Biol Cell. 2005;16:5445\u201354.","journal-title":"Mol Biol Cell"},{"key":"2762_CR79","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","volume":"18","author":"A Valenzuela-Fernandez","year":"2008","unstructured":"Valenzuela-Fernandez A, Cabrero JR, Serrador JM, Sanchez-Madrid F. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol. 2008;18:291\u20137.","journal-title":"Trends Cell Biol"},{"key":"2762_CR80","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/15384101.2017.1329067","volume":"17","author":"L Ling","year":"2018","unstructured":"Ling L, Hu F, Ying X, Ge J, Wang Q. HDAC6 inhibition disrupts maturational progression and meiotic apparatus assembly in mouse oocytes. Cell Cycle. 2018;17:550\u20136.","journal-title":"Cell Cycle"},{"key":"2762_CR81","doi-asserted-by":"crossref","unstructured":"Osseni A, Ravel-Chapuis A, Thomas JL, Gache V, Schaeffer L, Jasmin BJ. HDAC6 regulates microtubule stability and clustering of AChRs at neuromuscular junctions. J Cell Biol. 2020;219:e201901099.","DOI":"10.1083\/jcb.201901099"},{"key":"2762_CR82","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejcb.2005.11.001","volume":"85","author":"AD Bershadsky","year":"2006","unstructured":"Bershadsky AD, Ballestrem C, Carramusa L, Zilberman Y, Gilquin B, Khochbin S, Alexandrova AY, Verkhovsky AB, Shemesh T, Kozlov MM. Assembly and mechanosensory function of focal adhesions: experiments and models. Eur J Cell Biol. 2006;85:165\u201373.","journal-title":"Eur J Cell Biol"},{"key":"2762_CR83","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1038\/s41598-019-42075-3","volume":"9","author":"R Cabrera-Rodriguez","year":"2019","unstructured":"Cabrera-Rodriguez R, Hebmann V, Marfil S, Pernas M, Marrero-Hernandez S, Cabrera C, Urrea V, Casado C, Olivares I, Marquez-Arce D, et al. HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic. Sci Rep. 2019;9:5544.","journal-title":"Sci Rep"},{"key":"2762_CR84","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s40265-022-01786-0","volume":"82","author":"J Paik","year":"2022","unstructured":"Paik J. Lenacapavir: First Approval. Drugs. 2022;82:1499\u2013504.","journal-title":"Drugs"},{"key":"2762_CR85","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, Briner A, Rodriguez CM, Guo C, Akiyama T, et al. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature. 2022;603:124\u201330.","journal-title":"Nature"},{"key":"2762_CR86","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12977-015-0181-5","volume":"12","author":"MS Valera","year":"2015","unstructured":"Valera MS, de Armas-Rillo L, Barroso-Gonzalez J, Ziglio S, Batisse J, Dubois N, Marrero-Hernandez S, Borel S, Garcia-Exposito L, Biard-Piechaczyk M, et al. The HDAC6\/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation. Retrovirology. 2015;12:53.","journal-title":"Retrovirology"},{"key":"2762_CR87","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature10693","volume":"481","author":"S Jager","year":"2011","unstructured":"Jager S, Kim DY, Hultquist JF, Shindo K, LaRue RS, Kwon E, Li M, Anderson BD, Yen L, Stanley D, et al. Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature. 2011;481:371\u20135.","journal-title":"Nature"},{"key":"2762_CR88","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.molcel.2012.12.012","volume":"49","author":"DY Kim","year":"2013","unstructured":"Kim DY, Kwon E, Hartley PD, Crosby DC, Mann S, Krogan NJ, Gross JD. CBFbeta stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. Mol Cell. 2013;49:632\u201344.","journal-title":"Mol Cell"},{"key":"2762_CR89","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1128\/JVI.03604-13","volume":"88","author":"X Zhou","year":"2014","unstructured":"Zhou X, Han X, Zhao K, Du J, Evans SL, Wang H, Li P, Zheng W, Rui Y, Kang J, Yu XF. Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFbeta recruitment and A3G suppression. J Virol. 2014;88:2555\u201363.","journal-title":"J Virol"},{"key":"2762_CR90","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","volume":"115","author":"Y Kawaguchi","year":"2003","unstructured":"Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell. 2003;115:727\u201338.","journal-title":"Cell"},{"key":"2762_CR91","doi-asserted-by":"crossref","unstructured":"Seigneurin-Berny D, Verdel A, Curtet S, Lemercier C, Garin J, Rousseaux S, et al. Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways. Mol Cell Biol. 2001;21:8035\u201344.","DOI":"10.1128\/MCB.21.23.8035-8044.2001"},{"key":"2762_CR92","doi-asserted-by":"crossref","unstructured":"Hook SS, Orian A, Cowley SM, Eisenman RN. Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc Natl Acad Sci U S A. 2002;99:13425\u201330.","DOI":"10.1073\/pnas.172511699"},{"key":"2762_CR93","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3389\/fmicb.2019.02437","volume":"10","author":"S Marrero-Hernandez","year":"2019","unstructured":"Marrero-Hernandez S, Marquez-Arce D, Cabrera-Rodriguez R, Estevez-Herrera J, Perez-Yanes S, Barroso-Gonzalez J, Madrid R, Machado JD, Blanco J, Valenzuela-Fernandez A. HIV-1 Nef Targets HDAC6 to Assure Viral Production and Virus Infection. Front Microbiol. 2019;10:2437.","journal-title":"Front Microbiol"},{"key":"2762_CR94","doi-asserted-by":"crossref","unstructured":"Cabrera-Rodriguez R, Perez-Yanes S, Lorenzo-Sanchez I, Trujillo-Gonzalez R, Estevez-Herrera J, Garcia-Luis J, et al. HIV infection: shaping the complex, dynamic, and interconnected network of the Cytoskeleton. Int J Mol Sci. 2023;24:13104.","DOI":"10.3390\/ijms241713104"},{"key":"2762_CR95","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1128\/JVI.76.12.5959-5965.2002","volume":"76","author":"M Tobiume","year":"2002","unstructured":"Tobiume M, Takahoko M, Yamada T, Tatsumi M, Iwamoto A, Matsuda M. Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors. J Virol. 2002;76:5959\u201365.","journal-title":"J Virol"},{"key":"2762_CR96","first-page":"320","volume":"1","author":"U Visco-Comandini","year":"1998","unstructured":"Visco-Comandini U, Yun Z, Paganelli R, Orlandi P, Salotti A, Johansson B, Vahlne A, Sonnerborg A. HIV-1 nef mutations and clinical long-term nonprogression. A molecular epidemiology study. J Hum Virol. 1998;1:320\u20137.","journal-title":"J Hum Virol"},{"key":"2762_CR97","first-page":"1973","volume":"84","author":"HW Zhang","year":"2004","unstructured":"Zhang HW, Qiu ZF, Li TS. [HIV-1 nef specific cytotoxic T lymphocyte responses in long-term nonprogressors and AIDS patients]. Zhonghua Yi Xue Za Zhi. 2004;84:1973\u20136.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2762_CR98","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1089\/aid.2012.0020","volume":"28","author":"G Corro","year":"2012","unstructured":"Corro G, Rocco CA, De Candia C, Catano G, Turk G, Mangano A, Aulicino PC, Bologna R, Sen L. Genetic and functional analysis of HIV type 1 nef gene derived from long-term nonprogressor children: association of attenuated variants with slow progression to pediatric AIDS. AIDS Res Hum Retroviruses. 2012;28:1617\u201326.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2762_CR99","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00002030-200002180-00002","volume":"14","author":"B Wang","year":"2000","unstructured":"Wang B, Spira TJ, Owen S, Lal RB, Saksena NK. HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors. AIDS. 2000;14:213\u201323.","journal-title":"AIDS"},{"key":"2762_CR100","doi-asserted-by":"crossref","unstructured":"Ward AB, Wilson IA. Insights into the trimeric HIV-1 envelope glycoprotein structure. Trends Biochem Sci. 2015;40:101\u20137.","DOI":"10.1016\/j.tibs.2014.12.006"},{"key":"2762_CR101","doi-asserted-by":"crossref","unstructured":"Ward AB, Wilson IA. The HIV-1 envelope glycoprotein structure: nailing down a moving target. Immunol Rev. 2017;275:21\u201332.","DOI":"10.1111\/imr.12507"},{"key":"2762_CR102","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-1326-8-7","volume":"8","author":"C Simoes-Pires","year":"2013","unstructured":"Simoes-Pires C, Zwick V, Nurisso A, Schenker E, Carrupt PA, Cuendet M. HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? Mol Neurodegener. 2013;8:7.","journal-title":"Mol Neurodegener"},{"key":"2762_CR103","doi-asserted-by":"publisher","unstructured":"Gao J, Wang L, Huntley ML, Perry G, Wang X. Pathomechanisms of TDP-43 in neurodegeneration. J Neurochem. 2018: https:\/\/doi.org\/10.1111\/jnc.14327.","DOI":"10.1111\/jnc.14327"},{"key":"2762_CR104","doi-asserted-by":"publisher","first-page":"14","DOI":"10.15698\/cst2018.01.120","volume":"2","author":"W Guo","year":"2017","unstructured":"Guo W, Van Den Bosch L. Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis. Cell Stress. 2017;2:14\u20136.","journal-title":"Cell Stress"},{"key":"2762_CR105","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.bbrc.2012.11.034","volume":"430","author":"S Odagiri","year":"2013","unstructured":"Odagiri S, Tanji K, Mori F, Miki Y, Kakita A, Takahashi H, Wakabayashi K. Brain expression level and activity of HDAC6 protein in neurodegenerative dementia. Biochem Biophys Res Commun. 2013;430:394\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2762_CR106","doi-asserted-by":"publisher","first-page":"586453","DOI":"10.3389\/fnsyn.2020.586453","volume":"12","author":"M Lemos","year":"2020","unstructured":"Lemos M, Stefanova N. Histone Deacetylase 6 and the Disease Mechanisms of alpha-Synucleinopathies. Front Synaptic Neurosci. 2020;12:586453.","journal-title":"Front Synaptic Neurosci"},{"key":"2762_CR107","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1038\/s41467-020-19317-4","volume":"11","author":"H Trzeciakiewicz","year":"2020","unstructured":"Trzeciakiewicz H, Ajit D, Tseng JH, Chen Y, Ajit A, Tabassum Z, Lobrovich R, Peterson C, Riddick NV, Itano MS, et al. An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline. Nat Commun. 2020;11:5522.","journal-title":"Nat Commun"},{"key":"2762_CR108","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/jnen\/nlx025","volume":"76","author":"MD Cykowski","year":"2017","unstructured":"Cykowski MD, Powell SZ, Peterson LE, Appel JW, Rivera AL, Takei H, Chang E, Appel SH. Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis. J Neuropathol Exp Neurol. 2017;76:402\u201313.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2762_CR109","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00401-007-0226-5","volume":"114","author":"LK Kwong","year":"2007","unstructured":"Kwong LK, Neumann M, Sampathu DM, Lee VM, Trojanowski JQ. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol. 2007;114:63\u201370.","journal-title":"Acta Neuropathol"},{"key":"2762_CR110","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41419-019-1920-7","volume":"10","author":"ED Wenzel","year":"2019","unstructured":"Wenzel ED, Speidell A, Flowers SA, Wu C, Avdoshina V, Mocchetti I. Histone deacetylase 6 inhibition rescues axonal transport impairments and prevents the neurotoxicity of HIV-1 envelope protein gp120. Cell Death Dis. 2019;10:674.","journal-title":"Cell Death Dis"},{"key":"2762_CR111","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Yanes S, Lorenzo-S\u00e1nchez I, Cabrera-Rodr\u00edguez RA-O, Garc\u00eda-Luis JA-O, Trujillo-Gonz\u00e1lez RA-O, Est\u00e9vez-Herrera J, Valenzuela-Fern\u00e1ndez. AA-O: The ZIKV NS5 Protein Aberrantly Alters the Tubulin Cytoskeleton, Induces the Accumulation of Autophagic p62 and Affects IFN Production: HDAC6 Has Emerged as an Anti-NS5\/ZIKV Factor. LID\u2009\u2013. LID\u2009\u2013\u2009598. https:\/\/doi.org\/10.3390\/cells13070598.","DOI":"10.3390\/cells13070598"},{"key":"2762_CR112","doi-asserted-by":"crossref","unstructured":"Bartholomeeusen K, Fujinaga K, Xiang Y, Peterlin BM. Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription. J Biol Chem. 2013;288:14400\u20137.","DOI":"10.1074\/jbc.M113.464834"},{"key":"2762_CR113","doi-asserted-by":"publisher","first-page":"661446","DOI":"10.3389\/fmicb.2021.661446","volume":"12","author":"R Cabrera-Rodriguez","year":"2021","unstructured":"Cabrera-Rodriguez R, Perez-Yanes S, Estevez-Herrera J, Marquez-Arce D, Cabrera C, Espert L, Blanco J, Valenzuela-Fernandez A. The Interplay of HIV and Autophagy in Early Infection. Front Microbiol. 2021;12:661446.","journal-title":"Front Microbiol"},{"key":"2762_CR114","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11481-019-09886-7","volume":"16","author":"T Lanman","year":"2021","unstructured":"Lanman T, Letendre S, Ma Q, Bang A, Ellis R. CNS Neurotoxicity of Antiretrovirals. J Neuroimmune Pharmacol. 2021;16:130\u201343.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2762_CR115","doi-asserted-by":"publisher","first-page":"e70110","DOI":"10.1096\/fj.202400557RR","volume":"38","author":"Y Mai","year":"2024","unstructured":"Mai Y, Jing Z, Sun P, Wang Y, Dong P, Liu J. TARDBP drives T-cell acute lymphoblastic leukemia progression by binding MDM2 mRNA, involving beta-catenin pathway. FASEB J. 2024;38:e70110.","journal-title":"FASEB J"},{"key":"2762_CR116","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41467-023-37630-6","volume":"14","author":"OJ Ziff","year":"2023","unstructured":"Ziff OJ, Neeves J, Mitchell J, Tyzack G, Martinez-Ruiz C, Luisier R, Chakrabarti AM, McGranahan N, Litchfield K, Boulton SJ, et al. Integrated transcriptome landscape of ALS identifies genome instability linked to TDP-43 pathology. Nat Commun. 2023;14:2176.","journal-title":"Nat Commun"},{"key":"2762_CR117","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1101\/gr.275939.121","volume":"32","author":"OJ Ziff","year":"2022","unstructured":"Ziff OJ, Clarke BE, Taha DM, Crerar H, Luscombe NM, Patani R. Meta-analysis of human and mouse ALS astrocytes reveals multi-omic signatures of inflammatory reactive states. Genome Res. 2022;32:71\u201384.","journal-title":"Genome Res"},{"key":"2762_CR118","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S1474-4422(25)00109-7","volume":"24","author":"R Balendra","year":"2025","unstructured":"Balendra R, Sreedharan J, Hallegger M, Luisier R, Lashuel HA, Gregory JM, Patani R. Amyotrophic lateral sclerosis caused by TARDBP mutations: from genetics to TDP-43 proteinopathy. Lancet Neurol. 2025;24:456\u201370.","journal-title":"Lancet Neurol"},{"key":"2762_CR119","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1111\/j.1742-4658.2011.08258.x","volume":"278","author":"FC Fiesel","year":"2011","unstructured":"Fiesel FC, Kahle PJ. TDP-43 and FUS\/TLS: cellular functions and implications for neurodegeneration. FEBS J. 2011;278:3550\u201368.","journal-title":"FEBS J"},{"key":"2762_CR120","doi-asserted-by":"publisher","first-page":"e106177","DOI":"10.15252\/embj.2020106177","volume":"40","author":"R Fazal","year":"2021","unstructured":"Fazal R, Boeynaems S, Swijsen A, De Decker M, Fumagalli L, Moisse M, Vanneste J, Guo W, Boon R, Vercruysse T, et al. HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations. EMBO J. 2021;40:e106177.","journal-title":"EMBO J"},{"key":"2762_CR121","doi-asserted-by":"publisher","first-page":"117634","DOI":"10.1016\/j.ejmech.2025.117634","volume":"292","author":"S Barone","year":"2025","unstructured":"Barone S, Bello I, Guadagni A, Cerchia C, Filocamo G, Cassese E, Alfano AI, Esposito C, Feliz Morel AJ, Brunetti M, et al. Challenging triple negative breast cancer through HDAC6 selective inhibition: Novel cap-group identification, structure-activity relationships, computational and biological studies. Eur J Med Chem. 2025;292:117634.","journal-title":"Eur J Med Chem"},{"key":"2762_CR122","doi-asserted-by":"publisher","first-page":"115004","DOI":"10.1016\/j.ejmech.2022.115004","volume":"246","author":"J Yan","year":"2023","unstructured":"Yan J, Yue K, Fan X, Xu X, Wang J, Qin M, Zhang Q, Hou X, Li X, Wang Y. Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors. Eur J Med Chem. 2023;246:115004.","journal-title":"Eur J Med Chem"},{"key":"2762_CR123","doi-asserted-by":"publisher","first-page":"e10541","DOI":"10.1002\/btm2.10541","volume":"8","author":"S Tiwari","year":"2023","unstructured":"Tiwari S, Liu S, Anees M, Mehrotra N, Thakur A, Tawa GJ, Grewal G, Stone R, Kharbanda S, Singh H. Quatramer encapsulation of dual-targeted PI3-Kdelta\/HDAC6 inhibitor, HSB-510, suppresses growth of breast cancer. Bioeng Transl Med. 2023;8:e10541.","journal-title":"Bioeng Transl Med"},{"key":"2762_CR124","doi-asserted-by":"crossref","unstructured":"Pflieger M, Sonnichsen M, Horstick-Muche N, Yang J, Schliehe-Diecks J, Scholer A, et al. Oxa analogues of Nexturastat a demonstrate improved HDAC6 selectivity and superior Antileukaemia activity. ChemMedChem. 2021;16:1798\u2013803.","DOI":"10.1002\/cmdc.202001011"},{"key":"2762_CR125","doi-asserted-by":"publisher","unstructured":"Fathy A, Allam A, ElHady AK, El-Gamil DS, Lin KC, Chang YH, et al. Development of potent and selective tetrahydro-\u03b2-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer. RSC Med Chem. 2025. https:\/\/doi.org\/10.1039\/d5md00086f.","DOI":"10.1039\/d5md00086f"},{"key":"2762_CR126","doi-asserted-by":"crossref","unstructured":"Lee SW, Yeon SK, Kim GW, Lee DH, Jeon YH, Yoo J, et al. HDAC6-selective inhibitor overcomes Bortezomib resistance in multiple Myeloma. Int J Mol Sci. 2021;22:1341.","DOI":"10.3390\/ijms22031341"},{"key":"2762_CR127","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/glia.22865","volume":"63","author":"GS Youn","year":"2015","unstructured":"Youn GS, Ju SM, Choi SY, Park J. HDAC6 mediates HIV-1 tat-induced proinflammatory responses by regulating MAPK-NF-kappaB\/AP-1 pathways in astrocytes. Glia. 2015;63:1953\u201365.","journal-title":"Glia"},{"key":"2762_CR128","doi-asserted-by":"publisher","first-page":"10803","DOI":"10.1128\/JVI.00320-14","volume":"88","author":"MB Lucera","year":"2014","unstructured":"Lucera MB, Tilton CA, Mao H, Dobrowolski C, Tabler CO, Haqqani AA, Karn J, Tilton JC. The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4\u2009+\u2009T cells to HIV by increasing the kinetics and efficiency of postentry viral events. J Virol. 2014;88:10803\u201312.","journal-title":"J Virol"},{"key":"2762_CR129","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tim.2013.02.005","volume":"21","author":"K Shirakawa","year":"2013","unstructured":"Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E. Reactivation of latent HIV by histone deacetylase inhibitors. Trends Microbiol. 2013;21:277\u201385.","journal-title":"Trends Microbiol"},{"key":"2762_CR130","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1084\/jem.192.8.1081","volume":"192","author":"KF Ferri","year":"2000","unstructured":"Ferri KF, Jacotot E, Blanco J, Este JA, Zamzami N, Susin SA, Xie Z, Brothers G, Reed JC, Penninger JM, Kroemer G. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J Exp Med. 2000;192:1081\u201392.","journal-title":"J Exp Med"},{"key":"2762_CR131","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1189\/jlb.0204100","volume":"76","author":"J Blanco","year":"2004","unstructured":"Blanco J, Barretina J, Clotet B, Este JA. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism. J Leukoc Biol. 2004;76:804\u201311.","journal-title":"J Leukoc Biol"},{"key":"2762_CR132","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1046\/j.1468-3083.2003.00681.x","volume":"17","author":"DJ Bell","year":"2003","unstructured":"Bell DJ, Dockrell DH. Apoptosis in HIV-1 infection. J Eur Acad Dermatol Venereol. 2003;17:178\u201383.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2762_CR133","unstructured":"Cotton MF, Cassella C, Rapaport EL, Tseng PO, Marschner S, Finkel TH. Apoptosis in HIV-1 Infection. Behring Inst Mitt. 1996;(97):220\u201331."},{"key":"2762_CR134","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/cdd.2015.58","volume":"22","author":"G Fung","year":"2015","unstructured":"Fung G, Shi J, Deng H, Hou J, Wang C, Hong A, Zhang J, Jia W, Luo H. Cytoplasmic translocation, aggregation, and cleavage of TDP-43 by enteroviral proteases modulate viral pathogenesis. Cell Death Differ. 2015;22:2087\u201397.","journal-title":"Cell Death Differ"},{"key":"2762_CR135","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nbd.2016.06.017","volume":"94","author":"M Manghera","year":"2016","unstructured":"Manghera M, Ferguson-Parry J, Douville RN. TDP-43 regulates endogenous retrovirus-K viral protein accumulation. Neurobiol Dis. 2016;94:226\u201336.","journal-title":"Neurobiol Dis"},{"key":"2762_CR136","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/ana.22149","volume":"69","author":"R Douville","year":"2011","unstructured":"Douville R, Liu J, Rothstein J, Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol. 2011;69:141\u201351.","journal-title":"Ann Neurol"},{"key":"2762_CR137","doi-asserted-by":"publisher","first-page":"307ra153","DOI":"10.1126\/scitranslmed.aac8201","volume":"7","author":"W Li","year":"2015","unstructured":"Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K, et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. 2015;7:307ra153.","journal-title":"Sci Transl Med"},{"key":"2762_CR138","doi-asserted-by":"publisher","first-page":"9338","DOI":"10.1128\/JVI.01503-16","volume":"90","author":"M Manghera","year":"2016","unstructured":"Manghera M, Ferguson-Parry J, Lin R, Douville RN. NF-kappaB and IRF1 Induce Endogenous Retrovirus K Expression via Interferon-Stimulated Response Elements in Its 5\u2019 Long Terminal Repeat. J Virol. 2016;90:9338\u201349.","journal-title":"J Virol"},{"key":"2762_CR139","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1093\/hmg\/ddt349","volume":"22","author":"J Janssens","year":"2013","unstructured":"Janssens J, Van Broeckhoven C. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Hum Mol Genet. 2013;22:R77\u201387.","journal-title":"Hum Mol Genet"},{"key":"2762_CR140","doi-asserted-by":"publisher","first-page":"e97984","DOI":"10.1371\/journal.pone.0097984","volume":"9","author":"RK Bhat","year":"2014","unstructured":"Bhat RK, Rudnick W, Antony JM, Maingat F, Ellestad KK, Wheatley BM, Tonjes RR, Power C. Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV\/AIDS. PLoS ONE. 2014;9:e97984.","journal-title":"PLoS ONE"},{"key":"2762_CR141","doi-asserted-by":"crossref","unstructured":"Douville RN, Nath A. Human endogenous Retrovirus-K and TDP-43 expression bridges ALS and HIV Neuropathology. Front Microbiol. 2017;8:1986.","DOI":"10.3389\/fmicb.2017.01986"},{"key":"2762_CR142","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbrc.2021.03.100","volume":"554","author":"D Idrees","year":"2021","unstructured":"Idrees D, Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochem Biophys Res Commun. 2021;554:94\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"2762_CR143","doi-asserted-by":"crossref","unstructured":"Laudanski K, Hajj J, Restrepo M, Siddiq K, Okeke T, Rader DJ. Dynamic changes in central and peripheral neuro-injury vs. neuroprotective serum markers in COVID-19 are modulated by different types of anti-viral treatments but do not affect the incidence of late and early strokes. Biomedicines. 2021;9:1791.","DOI":"10.3390\/biomedicines9121791"},{"key":"2762_CR144","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12977-014-0068-x","volume":"11","author":"T Fricke","year":"2014","unstructured":"Fricke T, White TE, Schulte B, de Souza Aranha Vieira DA, Dharan A, Campbell EM, Brandariz-Nunez A, Diaz-Griffero F. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1. Retrovirology. 2014;11:68.","journal-title":"Retrovirology"},{"key":"2762_CR145","doi-asserted-by":"crossref","unstructured":"Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature. 2013;502:563\u20136.","DOI":"10.1038\/nature12653"},{"key":"2762_CR146","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1128\/JVI.00169-15","volume":"89","author":"C Goujon","year":"2015","unstructured":"Goujon C, Greenbury RA, Papaioannou S, Doyle T, Malim MH. A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2. J Virol. 2015;89:4676\u201380.","journal-title":"J Virol"},{"key":"2762_CR147","doi-asserted-by":"crossref","unstructured":"Price AJ, Fletcher AJ, Schaller T, Elliott T, Lee K, KewalRamani VN, et al. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog. 2012;8:e1002896.","DOI":"10.1371\/journal.ppat.1002896"},{"key":"2762_CR148","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.1128\/JVI.00325-11","volume":"85","author":"KA Matreyek","year":"2011","unstructured":"Matreyek KA, Engelman A. The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid. J Virol. 2011;85:7818\u201327.","journal-title":"J Virol"},{"key":"2762_CR149","doi-asserted-by":"publisher","first-page":"e1004459","DOI":"10.1371\/journal.ppat.1004459","volume":"10","author":"AJ Price","year":"2014","unstructured":"Price AJ, Jacques DA, McEwan WA, Fletcher AJ, Essig S, Chin JW, Halambage UD, Aiken C, James LC. Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly. PLoS Pathog. 2014;10:e1004459.","journal-title":"PLoS Pathog"},{"key":"2762_CR150","doi-asserted-by":"crossref","unstructured":"Blair WS, Pickford C, Irving SL, Brown DG, Anderson M, Bazin R, et al. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog. 2010;6:e1001220.","DOI":"10.1371\/journal.ppat.1001220"},{"key":"2762_CR151","doi-asserted-by":"crossref","unstructured":"Lamorte L, Titolo S, Lemke CT, Goudreau N, Mercier JF, Wardrop E, et al. Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes. Antimicrob Agents Chemother. 2013;57:4622\u201331.","DOI":"10.1128\/AAC.00985-13"},{"key":"2762_CR152","doi-asserted-by":"publisher","first-page":"e202314587","DOI":"10.1002\/anie.202314587","volume":"63","author":"L Yang","year":"2024","unstructured":"Yang L, Jasiqi Y, Zettor A, Vadas O, Chiaravalli J, Agou F, Lashuel HA. Effective Inhibition of TDP-43 Aggregation by Native State Stabilization. Angew Chem Int Ed Engl. 2024;63:e202314587.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2762_CR153","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.neuron.2019.05.048","volume":"103","author":"MY Fang","year":"2019","unstructured":"Fang MY, Markmiller S, Vu AQ, Javaherian A, Dowdle WE, Jolivet P, Bushway PJ, Castello NA, Baral A, Chan MY, et al. Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS\/FTD. Neuron. 2019;103:802\u2013e819811.","journal-title":"Neuron"},{"key":"2762_CR154","doi-asserted-by":"crossref","unstructured":"Babazadeh A, Rayner SL, Lee A, Chung RS. TDP-43 as a therapeutic target in neurodegenerative diseases: focusing on motor neuron disease and frontotemporal dementia. Ageing Res Rev. 2023;92:102085.","DOI":"10.1016\/j.arr.2023.102085"},{"key":"2762_CR155","doi-asserted-by":"publisher","unstructured":"Akbar A, Haider R, Agnello L, Noor B, Maqsood N, Atif F, Ali W, Ciaccio MA-O, Tariq H. CRISPR in Neurodegenerative Diseases Treatment: An Alternative Approach to Current Therapies. LID\u2009\u2013. LID\u2009\u2013\u2009850. https:\/\/doi.org\/10.3390\/genes16080850.","DOI":"10.3390\/genes16080850"},{"key":"2762_CR156","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1038\/s41467-023-42147-z","volume":"14","author":"CM Zeballos","year":"2023","unstructured":"Zeballos CM, Moore HJ, Smith TJ, Powell JE, Ahsan NS, Zhang S, Gaj T. Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins. Nat Commun. 2023;14:6492.","journal-title":"Nat Commun"},{"key":"2762_CR157","doi-asserted-by":"crossref","unstructured":"Zhang G, Campbell GR, Zhang Q, Maule E, Hanna J, Gao W, et al. CD4(+) T cell-mimicking nanoparticles broadly neutralize HIV-1 and Suppress Viral Replication through Autophagy. mBio. 2020;11:e00903\u201320.","DOI":"10.1128\/mBio.00903-20"},{"key":"2762_CR158","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1038\/s41467-025-60001-2","volume":"16","author":"PM Cevaal","year":"2025","unstructured":"Cevaal PM, Kan S, Fisher BM, Moso MA, Tan A, Liu H, Ali A, Tanaka K, Shepherd RA, Kim Y, et al. Efficient mRNA delivery to resting T cells to reverse HIV latency. Nat Commun. 2025;16:4979.","journal-title":"Nat Commun"},{"key":"2762_CR159","doi-asserted-by":"publisher","first-page":"13877","DOI":"10.2147\/IJN.S540578","volume":"20","author":"G Das","year":"2025","unstructured":"Das G, Shin HS, Patra JK. Recent Advances in Nanoparticle-Based Antiretroviral Drug Delivery Systems for HIV Treatment and Prevention: A Comprehensive Review. Int J Nanomed. 2025;20:13877\u2013909.","journal-title":"Int J Nanomed"},{"key":"2762_CR160","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11904-025-00723-6","volume":"22","author":"W Chen","year":"2025","unstructured":"Chen W, Berkhout B, Pasternak AO. Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places. Curr HIV\/AIDS Rep. 2025;22:15.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2762_CR161","doi-asserted-by":"publisher","first-page":"e0065525","DOI":"10.1128\/mbio.00655-25","volume":"16","author":"N Mbhele","year":"2025","unstructured":"Mbhele N, Chimukangara B, Tyers L, Maldarelli F, Redd AD. Advancements in single-cell techniques for examining the HIV reservoir: pathways to a cure. mBio. 2025;16:e0065525.","journal-title":"mBio"},{"key":"2762_CR162","doi-asserted-by":"crossref","unstructured":"Ta TM, Malik S, Anderson EM, Jones AD, Perchik J, Freylikh M, et al. Insights into persistent HIV-1 infection and functional cure: novel capabilities and strategies. Front Microbiol. 2022;13:862270.","DOI":"10.3389\/fmicb.2022.862270"},{"key":"2762_CR163","doi-asserted-by":"crossref","unstructured":"Chvatal-Medina M, Lopez-Guzman C, Diaz FJ, Gallego S, Rugeles MT, Taborda NA. Molecular mechanisms by which the HIV-1 latent reservoir is established and therapeutic strategies for its elimination. Arch Virol. 2023;168:218.","DOI":"10.1007\/s00705-023-05800-y"},{"key":"2762_CR164","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.3389\/fmicb.2019.02878","volume":"10","author":"SD Falcinelli","year":"2019","unstructured":"Falcinelli SD, Ceriani C, Margolis DM, Archin NM. New Frontiers in Measuring and Characterizing the HIV Reservoir. Front Microbiol. 2019;10:2878.","journal-title":"Front Microbiol"},{"key":"2762_CR165","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/infdis\/jiad381","volume":"229","author":"H Roux","year":"2024","unstructured":"Roux H, Chomont N. Measuring Human Immunodeficiency Virus Reservoirs: Do We Need to Choose Between Quantity and Quality? J Infect Dis. 2024;229:635\u201343.","journal-title":"J Infect Dis"},{"key":"2762_CR166","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0140-6736(23)01381-8","volume":"403","author":"A Mody","year":"2024","unstructured":"Mody A, Sohn AH, Iwuji C, Tan RKJ, Venter F, Geng EH. HIV epidemiology, prevention, treatment, and implementation strategies for public health. Lancet. 2024;403:471\u201392.","journal-title":"Lancet"},{"key":"2762_CR167","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","volume":"11","author":"WM Pardridge","year":"2019","unstructured":"Pardridge WM. Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain. Front Aging Neurosci. 2019;11:373.","journal-title":"Front Aging Neurosci"},{"key":"2762_CR168","doi-asserted-by":"publisher","first-page":"e0180422","DOI":"10.1128\/mbio.01804-22","volume":"13","author":"SM Bester","year":"2022","unstructured":"Bester SM, Adu-Ampratwum D, Annamalai AS, Wei G, Briganti L, Murphy BC, Haney R, Fuchs JR, Kvaratskhelia M. Structural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir. mBio. 2022;13:e0180422.","journal-title":"mBio"},{"key":"2762_CR169","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/apc.2023.0028","volume":"37","author":"K Li","year":"2023","unstructured":"Li K, Liu B, Ma R, Zhang Q. HIV Tissue Reservoirs: Current Advances in Research. AIDS Patient Care STDS. 2023;37:284\u201396.","journal-title":"AIDS Patient Care STDS"},{"key":"2762_CR170","doi-asserted-by":"crossref","unstructured":"L\u00e9pine S, Maussion G, Schneider A, Nauleau-Javaudin A, Castellanos-Montiel MJ, Ambriz GJ, et al. Transcriptome-based screening in TARDBP\/TDP-43 knock-in motor neurons identifies the NEDD8-activating enzyme inhibitor MLN4924. Sci Rep. 2025;15:28555.","DOI":"10.1038\/s41598-025-12147-8"},{"issue":"Suppl 3","key":"2762_CR171","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2202-9-S3-S4","volume":"9","author":"GA Silva","year":"2008","unstructured":"Silva GA. Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. BMC Neurosci. 2008;9(Suppl 3):S4.","journal-title":"BMC Neurosci"},{"key":"2762_CR172","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/hiv.70092","volume":"26","author":"A Weibull Warnberg","year":"2025","unstructured":"Weibull Warnberg A, Cena-Diez R, Sonnerborg A, van de Klundert MAA. Natural occurrence of drug resistance mutations to the HIV-1 capsid inhibitor lenacapavir. HIV Med. 2025;26:1881\u20136.","journal-title":"HIV Med"},{"key":"2762_CR173","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/infdis\/jiaf050","volume":"231","author":"NA Margot","year":"2025","unstructured":"Margot NA, Jogiraju V, Pennetzdorfer N, Naik V, VanderVeen LA, Ling J, Singh R, Dvory-Sobol H, Ogbuagu O, Segal-Maurer S, et al. Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 Years. J Infect Dis. 2025;231:1239\u201345.","journal-title":"J Infect Dis"},{"key":"2762_CR174","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1016\/j.apsb.2024.08.009","volume":"14","author":"C Ma","year":"2024","unstructured":"Ma C, Chang J, Yu B. Sunlenca(R) (Lenacapavir): A first-in-class, long-acting HIV-1 capsid inhibitor for treating highly multidrug-resistant HIV-1 infection. Acta Pharm Sin B. 2024;14:5512\u20134.","journal-title":"Acta Pharm Sin B"},{"key":"2762_CR175","doi-asserted-by":"crossref","unstructured":"Henderson LJ, Reoma LB, Kovacs JA, Nath A. Advances toward Curing HIV-1 Infection in Tissue Reservoirs. J Virol. 2020;94:e00375\u201319.","DOI":"10.1128\/JVI.00375-19"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02762-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02762-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02762-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:04:09Z","timestamp":1778191449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02762-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":175,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2762"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02762-x","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"281"}}